- Filed
- Mar 30, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Mar 30, 2021 | 14.81M sh |
| Net Income | FY 2020 · Dec 31, 2020 | $3.28M |
| Net Income | FY 2020 · Dec 31, 2019 | $1.27M |
| Capex | FY 2020 · Dec 31, 2019 | $8.68M |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | $3.99M |
| Current Liabilities | FY 2020 · Dec 31, 2019 | $173.98M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $182.52M |
| Current Assets | FY 2020 · Dec 31, 2019 | $213.76M |
| Total Assets | FY 2020 · Dec 31, 2019 | $301.67M |
| Sga Expense | FY 2020 · Dec 31, 2019 | $35.12M |
| Rd Expense restated | FY 2020 · Dec 31, 2019 | $1M |
| Operating Income | FY 2020 · Dec 31, 2019 | $3.47M |
| Gross Profit | FY 2020 · Dec 31, 2019 | $118.77M |
| Cost Of Revenue | FY 2020 · Dec 31, 2019 | $264.33M |
| Revenue | FY 2020 · Dec 31, 2019 | $383.1M |
| Cash And Equivalents | FY 2020 · Dec 31, 2018 | $47.01M |